Milo Biotechnology is a Cleveland-based company dedicated to improving the lives of patients with neuromuscular diseases.

Milo’s early clinical-stage follistatin program, exclusively licensed from Nationwide Children’s Hospital, is designed to increase muscle size and strength.

Industry Sector
Biomedical & Health Tech

Founded
2011

JumpStart Investment
Evergreen Fund